507789 Stock Overview
Jagsonpal Pharmaceuticals Limited engages in the manufacture and trading of pharmaceutical products and active pharmaceutical ingredients in the areas in the areas of women health, pain and analgesics, and general medicine in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Jagsonpal Pharmaceuticals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹323.05 |
| 52 Week High | ₹513.90 |
| 52 Week Low | ₹270.05 |
| Beta | 0.99 |
| 1 Month Change | 12.46% |
| 3 Month Change | -15.02% |
| 1 Year Change | -10.59% |
| 3 Year Change | 248.11% |
| 5 Year Change | 1,149.71% |
| Change since IPO | 1,782.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| 507789 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 9.0% | -2.8% | -1.5% |
| 1Y | -10.6% | 54.9% | 45.0% |
Return vs Industry: 507789 underperformed the Indian Pharmaceuticals industry which returned 54.9% over the past year.
Return vs Market: 507789 underperformed the Indian Market which returned 45% over the past year.
Price Volatility
| 507789 volatility | |
|---|---|
| 507789 Average Weekly Movement | 7.9% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 507789 has not had significant price volatility in the past 3 months.
Volatility Over Time: 507789's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1978 | 940 | Manish Gupta | www.jagsonpal.com |
Jagsonpal Pharmaceuticals Limited engages in the manufacture and trading of pharmaceutical products and active pharmaceutical ingredients in the areas in the areas of women health, pain and analgesics, and general medicine in India and internationally. It offers pharmaceutical formulations and over the counter drugs in the areas of gynaecology, orthopaedics, and allergy management. It offers drugs in the form of tablets, softgels, injections, capsules, and syrups.
Jagsonpal Pharmaceuticals Limited Fundamentals Summary
| 507789 fundamental statistics | |
|---|---|
| Market cap | ₹8.50b |
| Earnings (TTM) | ₹245.17m |
| Revenue (TTM) | ₹2.21b |
34.7x
P/E Ratio3.9x
P/S RatioIs 507789 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 507789 income statement (TTM) | |
|---|---|
| Revenue | ₹2.21b |
| Cost of Revenue | ₹858.09m |
| Gross Profit | ₹1.35b |
| Other Expenses | ₹1.10b |
| Earnings | ₹245.17m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 9.27 |
| Gross Margin | 61.11% |
| Net Profit Margin | 11.11% |
| Debt/Equity Ratio | 5.5% |
How did 507789 perform over the long term?
See historical performance and comparison